Jaguar Health Statistics

Total Valuation

Jaguar Health has a market cap or net worth of $20.83 million. The enterprise value is $42.61 million.

Market Cap	20.83M
Enterprise Value	42.61M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Jaguar Health has 4.89 million shares outstanding. The number of shares has increased by 3,008.70% in one year.

Shares Outstanding	4.89M
Shares Change (YoY)	+3,008.70%
Shares Change (QoQ)	+588.57%
Owned by Insiders (%)	11.74%
Owned by Institutions (%)	1.66%
Float	4.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.05
Forward PS	1.23
PB Ratio	1.74
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 2.79.

Current Ratio	1.89
Quick Ratio	0.75
Debt / Equity	2.79
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.96

Financial Efficiency

Return on equity (ROE) is -639.90% and return on invested capital (ROIC) is -71.89%.

Return on Equity (ROE)	-639.90%
Return on Assets (ROA)	-75.30%
Return on Capital (ROIC)	-71.89%
Revenue Per Employee	$206,939
Profits Per Employee	-$782,122
Employee Count	49
Asset Turnover	0.20
Inventory Turnover	0.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.85% in the last 52 weeks. The beta is 0.88, so Jaguar Health's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	-86.85%
50-Day Moving Average	6.30
200-Day Moving Average	9.92
Relative Strength Index (RSI)	46.71
Average Volume (20 Days)	477,622

Short Selling Information

The latest short interest is 313,010, so 6.40% of the outstanding shares have been sold short.

Short Interest	313,010
Short Previous Month	353,382
Short % of Shares Out	6.40%
Short % of Float	7.39%
Short Ratio (days to cover)	0.39

Income Statement

In the last 12 months, Jaguar Health had revenue of $10.14 million and -$38.32 million in losses. Loss per share was -$26.40.

Revenue	10.14M
Gross Profit	8.02M
Operating Income	-32.68M
Pretax Income	-38.32M
Net Income	-38.32M
EBITDA	-31.07M
EBIT	-33.51M
Loss Per Share	-$26.40

Full Income Statement

Balance Sheet

The company has $11.67 million in cash and $33.46 million in debt, giving a net cash position of -$21.78 million or -$4.46 per share.

Cash & Cash Equivalents	11.67M
Total Debt	33.46M
Net Cash	-21.78M
Net Cash Per Share	-$4.46
Equity (Book Value)	12.00M
Book Value Per Share	2.45
Working Capital	15.90M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-30.34M
Capital Expenditures	n/a
Free Cash Flow	-30.34M
FCF Per Share	-$11.46

Full Cash Flow Statement

Margins

Gross margin is 79.07%, with operating and profit margins of -322.24% and -377.95%.

Gross Margin	79.07%
Operating Margin	-322.24%
Pretax Margin	-377.95%
Profit Margin	-377.95%
EBITDA Margin	-306.36%
EBIT Margin	-330.49%
FCF Margin	-299.25%

Dividends & Yields

Jaguar Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3,008.70%
Shareholder Yield	-3,008.70%
Earnings Yield	-184.00%
FCF Yield	-145.69%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on May 23, 2024. It was a reverse split with a ratio of 1:60.

Last Split Date	May 23, 2024
Split Type	Reverse
Split Ratio	1:60

Scores

Jaguar Health has an Altman Z-Score of -9.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.18
Piotroski F-Score	2